BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6661217)

  • 1. Chemical rearrangement of phenol-epoxide metabolites of polycyclic aromatic hydrocarbons to quinone-methides.
    Hulbert PB; Grover PL
    Biochem Biophys Res Commun; 1983 Nov; 117(1):129-34. PubMed ID: 6661217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically-active and chemically-reactive polycyclic hydrocarbon metabolites.
    Phillips DH; Grover PL
    IARC Sci Publ; 1984; (59):47-61. PubMed ID: 6545297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts.
    Day BW; Naylor S; Gan LS; Sahali Y; Nguyen TT; Skipper PL; Wishnok JS; Tannenbaum SR
    Cancer Res; 1990 Aug; 50(15):4611-8. PubMed ID: 2369737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular orbital studies of epoxide stability of carcinogenic polycyclic aromatic hydrocarbon diol epoxides.
    Adams SM; Kaminsky LS
    Mol Pharmacol; 1982 Sep; 22(2):459-64. PubMed ID: 7144738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.
    Wood AW; Huang MT; Chang RL; Newmark HL; Lehr RE; Yagi H; Sayer JM; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5513-7. PubMed ID: 6752950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis.
    Sims P; Grover PL
    Adv Cancer Res; 1974; 20():165-274. PubMed ID: 4617500
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular orbital study on the metabolic pathway through the diol epoxide form of carcinogenic benzene in comparison with benzo[a]pyrene.
    Imamura A; Tani S; Kanda K
    J Theor Biol; 1988 Nov; 135(2):215-8. PubMed ID: 3151696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular orbital treatment on the reactivity of some polycyclic aromatic hydrocarbon diol-epoxides.
    Imamura A; Ohsaku M
    J Theor Biol; 1983 Jun; 102(4):511-9. PubMed ID: 6413785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is intercalation a critical factor in the covalent binding of mutagenic and tumorigenic polycyclic aromatic diol epoxides to DNA?
    Geacintov NE
    Carcinogenesis; 1986 May; 7(5):759-66. PubMed ID: 3698204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of ultimate mutagenic species by diverse enzymes.
    Oesch F; Doehmer J; Friedberg T; Glatt H; Oesch-Bartlomowicz B; Platt KL; Steinberg P; Utesch D; Thomas H
    Prog Clin Biol Res; 1990; 340B():49-65. PubMed ID: 2168050
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro formation of glutathione conjugates from the K-region epoxides of 1-nitropyrene.
    Djurić Z; Coles B; Fifer EK; Ketterer B; Beland FA
    Carcinogenesis; 1987 Dec; 8(12):1781-6. PubMed ID: 3677304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "K-region" oxides and related oxidized metabolites of carcinogenic aromatic hydrocarbons.
    Harvey RG; Goh SH; Cortez C
    J Am Chem Soc; 1975 Jun; 97(12):3468-79. PubMed ID: 1141576
    [No Abstract]   [Full Text] [Related]  

  • 14. Senescent changes in rodent hepatic epoxide metabolism.
    Birnbaum LS; Baird MB
    Chem Biol Interact; 1979 Aug; 26(3):245-56. PubMed ID: 509688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids.
    Huang MT; Wood AW; Newmark HL; Sayer JM; Yagi H; Jerina DM; Conney AH
    Carcinogenesis; 1983 Dec; 4(12):1631-7. PubMed ID: 6360409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolites of 1,2-epoxy-3-phenoxy- and 1,2-epoxy-3-(p-nitrophenoxy)propane.
    James SP; Pheasant AE; Solheim E
    Xenobiotica; 1978 Apr; 8(4):219-28. PubMed ID: 645105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes.
    Nordqvist M; Thakker DR; Vyas KP; Yagi H; Levin W; Ryan DE; Thomas PE; Conney AH; Jerina DM
    Mol Pharmacol; 1981 Jan; 19(1):168-78. PubMed ID: 7207460
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrofluorescence study of polycyclic hydrocarbon diol-epoxide binding to DNA.
    Ridler PJ; Jennings BR; Osborne M; Brookes P
    Proc R Soc Lond B Biol Sci; 1986 May; 227(1249):441-54. PubMed ID: 2873577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenicity of methylated hydrocarbons: effect of methylation on the calculated diol-epoxide reactivity.
    Silverman BD; Lowe JP
    Cancer Biochem Biophys; 1982; 6(2):89-94. PubMed ID: 7151036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure--mutagenicity relationships for chlorinated ethylenes: a model based on the stability of the metabolically derived epoxides.
    Jones RB; Mackrodt WC
    Biochem Pharmacol; 1982 Nov; 31(22):3710-2. PubMed ID: 7181961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.